{
  "PostValue": {
    "post_id": "4ywoSYHLqPcb2JGMF",
    "value_ea": 5,
    "value_humanity": 3,
    "explanation": "This is a useful, but not foundational, post. For the EA/community it matters moderately: GiveWell\u2019s contraception CEA is consequential for funding/prioritization, and MSI\u2019s endorsement, data, and discussion of modeling and equity help inform and refine those analyses and operational decisions. It\u2019s valuable corroboration and a practical perspective from a large provider, but it doesn\u2019t introduce radically new evidence or overturn major views. For general humanity the post is of minor importance: it promotes an important intervention (contraception) and highlights equity concerns, but it\u2019s mainly organizational commentary rather than a direct, large-scale policy or scientific breakthrough."
  },
  "PostRobustness": {
    "post_id": "4ywoSYHLqPcb2JGMF",
    "robustness_score": 3,
    "actionable_feedback": "1) Substantiate and qualify your empirical claims. Several headline statistics (\"98% of clients report a positive impact\", \"two-thirds... only known source of contraception\") are plausive but lack methodological detail. Before publishing, add brief notes or links on sample sizes, question wording, timing (exit interview vs. follow-up), how you correct for selection or social-desirability bias, and how you identified \"only known source\". If space is tight, convert these into a single linked footnote to a methods appendix or dataset. This prevents readers from dismissing the piece as promotional.\n\n2) Acknowledge limitations and major counterarguments that GiveWell emphasizes. The post currently reads as celebratory rather than analytical. Explicitly note the main sources of uncertainty in cost-effectiveness estimates (counterfactual assumptions, cross-intervention comparability, long-term vs. short-term outcomes) and any weaknesses in your own Impact 2 model (e.g., reliance on self-report, limited longitudinal data). Say how you will test robustness (sensitivity analyses, alternative counterfactuals) and what evidence would change MSI\u2019s priorities. That will make the piece more credible to technical EA readers.\n\n3) Add one or two concrete, actionable follow-ups rather than general commitments. Readers (and potential collaborators at EA Global) will want specifics: e.g., \"We will publish updated Impact 2 vX by [date] including X equity-weighting method and Y scenario analyses; code and data will be posted at [repo].\" Or \"We invite replication partners for a sensitivity analysis on parameter Z\u2014contact [email].\" Small, concrete next steps and a clearer delineation of where you and GiveWell meaningfully differ will make the post far more useful.",
    "improvement_potential": "Targets major credibility gaps for an EA/technical audience: missing methodological details for headline stats, lack of acknowledged limitations/uncertainty, and absence of concrete next steps. Implementing these fixes would substantially reduce the piece\u2019s promotional feel and make it far more useful to researchers and donors, without requiring a long rewrite. It\u2019s not a 10 because the post\u2019s overall thesis isn\u2019t wrong and the feedback could be slightly more specific about which sensitivity analyses or counterfactuals to run."
  },
  "PostAuthorAura": {
    "post_id": "4ywoSYHLqPcb2JGMF",
    "author_fame_ea": 1,
    "author_fame_humanity": 2,
    "explanation": "I do not recognize Meghan Blake as a known figure in the EA/rationalist community (no notable posts on EA forums, LessWrong, or EA-affiliated publications up to my 2024 cutoff). Outside EA there may be people named Meghan Blake who are authors/journalists with minor online presence, but no widely known public profile. If you can provide a link or more context (books, articles, handles), I can reassess more precisely."
  },
  "PostClarity": {
    "post_id": "4ywoSYHLqPcb2JGMF",
    "clarity_score": 8,
    "explanation": "Overall clear and well-structured: the post states its purpose, cites GiveWell\u2019s work, summarizes MSI\u2019s supporting data and collaboration, and outlines next steps. Strengths include logical flow, concrete statistics, and a clear call to engage. Weaknesses: occasional wordiness/repetition, a minor grammatical error (\u201cimpact of contraception their lives\u201d missing \u201con\u201d), and a couple of small formatting/name issues (e.g., \u201cAnisaBerdellima\u201d missing a space). The argument is persuasive but could be tightened and made slightly more specific about which methodological differences matter."
  },
  "PostNovelty": {
    "post_id": "4ywoSYHLqPcb2JGMF",
    "novelty_ea": 3,
    "novelty_humanity": 4,
    "explanation": "The post is largely a policy/communications response rather than presenting new theoretical claims. For EA Forum readers, the main claims (contraception is highly cost\u2011effective and worth modeling; GiveWell\u2019s analysis is useful; equity matters in valuation) are already familiar, so novelty is low. The most novel elements are MSI\u2019s specific data points (large client survey results, two\u2011thirds being the only known source) and the stated plans to add more dynamic, equity\u2011focused modelling to Impact 2. For the general public, those concrete data and the emphasis on changing modelling to reflect distributional effects are somewhat less common knowledge, but the core ideas remain broadly well known."
  },
  "PostInferentialSupport": {
    "post_id": "4ywoSYHLqPcb2JGMF",
    "reasoning_quality": 5,
    "evidence_quality": 4,
    "overall_support": 5,
    "explanation": "Strengths: the post is logically organized, acknowledges GiveWell\u2019s work, draws on substantial program experience and large internal survey samples, and sensibly flags equity and modelling improvements. Weaknesses: the argument relies mainly on internal, self-reported client-exit data and high-level program metrics (with few external citations or methodological detail), does not address potential biases or counterfactuals, and omits supporting peer\u2011reviewed evidence or transparent cost\u2011effectiveness figures. Overall, the claims are plausible and directionally supported but not robustly evidenced for rigorous evaluative purposes."
  },
  "PostExternalValidation": {
    "post_id": "4ywoSYHLqPcb2JGMF",
    "emperical_claim_validation_score": 7,
    "validation_notes": "Mostly accurate and verifiable on major points, with a few specific figures that are either not publicly documented or slightly misstated. Strengths: GiveWell\u2019s contraception cost\u2011effectiveness analysis exists and explicitly compares to MSI\u2019s Impact 2; MSI\u2019s age, scope and scale claims (founded 1976, ~50 years; active in ~36 countries; >200 million clients by 2023 and ~23.8M served in 2024) are documented; MSI does maintain large client exit interview (CEI) programs and reports high client satisfaction and heavy reach into poorer, younger, rural populations (MSI reports ~60% of clients knew no other source). Impact 2 is publicly available and has been described in peer\u2011reviewed literature. Weaknesses / caveats: the post\u2019s specific CEI counts (\"over 15,000 client exit interviews in 2024 alone\" and \"215,000 over past decade\") are not directly supported by MSI\u2019s publicly posted figures (MSI\u2019s technical pages report 180k+ CEIs since 2011); the label \u201copen\u2011source\u201d for Impact 2 is imprecise (MSI makes Impact 2 publicly downloadable but it is copyrighted with use/modification restrictions rather than an open\u2011source license). The 98% figure for \"clients report a positive impact\" is not cited on MSI public pages I could find, though MSI CEI materials show very high satisfaction levels\u2014so that exact percentage remains unverified in public sources. The statement about maternal mortality being substantially higher for the poorest is supported by peer\u2011reviewed analyses (large wealth gradients in maternal deaths in Nigeria), so that example is reasonable.",
    "sources": [
      "GiveWell \u2014 Valuing Contraception in GiveWell\u2019s Cost\u2011Effectiveness Analysis (GiveWell page and spreadsheet). ([givewell.org](https://www.givewell.org/how-we-work/our-criteria/cost-effectiveness/valuing-contraception?utm_source=chatgpt.com))",
      "MSI Reproductive Choices \u2014 Impact (2024 Impact summary and 2024 Impact Brief). ([msichoices.org](https://www.msichoices.org/latest/msi-2024-impact-brief/?utm_source=chatgpt.com))",
      "MSI Reproductive Choices \u2014 Our story / Who we are (founded 1976; ~50 years; daily clients ~94,000; >200M clients by 2023). ([msichoices.org](https://www.msichoices.org/who-we-are/our-story/?utm_source=chatgpt.com))",
      "MSI Reproductive Choices \u2014 Technical Expertise page (Client Exit Interviews: '180k+ interviews since 2011'; Impact 2 description and download). ([msichoices.org](https://www.msichoices.org/what-we-do/technical-expertise/))",
      "MSI website content: statement that ~6 in 10 clients knew of no other way to access family planning (support for the 'only known source' claim). ([msiunitedstates.org](https://www.msiunitedstates.org/traveling-to-the-most-remote-communities/?utm_source=chatgpt.com))",
      "BMC Public Health / PMC \u2014 'Estimating the contribution ... Impact 2 model' (peer\u2011reviewed paper describing Impact 2, 2013). ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3684538/?utm_source=chatgpt.com))",
      "Lancet Global Health (2023) \u2014 'Effects of public financing ... across wealth quintiles in Nigeria' (shows large wealth gradients / maternal deaths by quintile). ([thelancet.com](https://www.thelancet.com/journals/langlo/article/PIIS2214-109X%2823%2900056-6/fulltext?utm_source=chatgpt.com))",
      "Rethink Priorities \u2014 family planning evidence review (background on evidence and work GiveWell commissioned). ([rethinkpriorities.org](https://rethinkpriorities.org/research-area/evidence-review-family-planning-interventions/?utm_source=chatgpt.com))",
      "GiveWell page comparison noting Rethink Priorities replicated Impact 2 and compared models (supports MSI\u2013GiveWell\u2013Rethink Priorities engagement). ([givewell.org](https://www.givewell.org/how-we-work/our-criteria/cost-effectiveness/valuing-contraception?utm_source=chatgpt.com))"
    ]
  }
}